Funding focus: Biotech dominates Netherlands’ top 10 rounds in H1 2025

Funding focus is a new series analysing cash flow into the European tech ecosystem. After debuting with a look at the biggest rounds so far this year, we now turn to the largest deals in the Netherlands for H1. Startups in the Netherlands raised just $503mn (€429mn) in the first quarter of this year — the lowest quarterly total since the early days of the COVID-19 pandemic, according to Dealroom data. But three months later, the outlook has improved. Total funding for the first half of 2025 hit $1.4bn (€1.2bn). That’s down from $1.8bn (€1.54bn) at the same point last…

This story continues at The Next Web